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ABSTRACT16
We studied the transcriptomic response of Streptococcus pneumoniae to the17
fluoroquinolone moxifloxacin at a concentration that inhibits DNA gyrase. Treatment of18
the wild-type strain R6, at a concentration of 10× MIC, triggered a response involving19
132 genes after 30 minutes of treatment. Genes from several metabolic pathways20
involved in the production of pyruvate were up-regulated. These included 3 glycolytic21
enzymes, which ultimately convert fructose-6P to pyruvate, and 2 enzymes that funnel22
P-sugars into the glycolytic pathway. In addition, acetyl-CoA carboxylase was down-23
regulated, likely leading to an increase in acetyl-CoA. When coupled with an up-24
regulation in formate acetyltransferase, an increase in acetyl-CoA would raise the25
production of pyruvate. Since pyruvate is converted by pyruvate oxidase (SpxB) into26
hydrogen peroxide (H2O2), an increase in pyruvate would augment intracellular H2O2.27
Here, we confirm a 21-fold increase in the production of H2O2 and a 55-fold increase in28
the amount of hydroxyl radical in cultures treated during 4 h with moxifloxacin. This29
increase in hydroxyl radical through the Fenton reaction, would damage DNA, lipids,30
and proteins. These reactive oxygen species contributed to the lethality of the drug, a31
conclusion supported by the observed protective effects of a SpxB deletion. These32
results support the model whereby fluoroquinolones cause redox alterations. The33
transcriptional response of S. pneumoniae to moxifloxacin is compared with the34
response to levofloxacin, an inhibitor of topoisomerase IV. Levofloxacin triggers the35
transcriptional activation of iron transport genes and also enhances the Fenton reaction.36
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Streptococcus pneumoniae (the pneumococcus) is an important human pathogen. It is37
the primary cause of community-acquired pneumonia, meningitis, bacteremia, and otitis38
media in children. Worldwide, one million children 5 years of age and under die39
annually of pneumococcal infections (1). Isolates of S. pneumoniae resistant to beta-40
lactams, which act on the cell wall, and macrolides, which inhibit protein synthesis,41
have proliferated in the last three decades (2). The fluoroquinolones (FQs) levofloxacin42
(LVX) and moxifloxacin (MOX) are currently used for the treatment of adult patients43
with pneumonia. FQ-resistance in S. pneumoniae is minimally prevalent (< 3%) in44
Europe (3, 4), although higher rates have been detected in Asia (10.5%) (5) and in45
Canada (7.3%)(6). This low prevalence allows successful treatment of pneumococcal46
pneumonia with FQs. However, an increase in resistance may occur in tandem with the47
increased use of FQs (7). FQs target the type II DNA topoisomerases: DNA gyrase48
(gyrase) and DNA topoisomerase IV (topo IV). These enzymes manage DNA topology49
and solve topological problems associated with DNA replication, transcription, and50
recombination (8). Gyrase introduces negative supercoils into DNA (9) whereas topo IV51
relaxes DNA and participates in chromosome partitioning (10). In S. pneumoniae, the52
primary target for most FQs, including LVX, is topo IV (11, 12), while gyrase has been53
described as the primary target for MOX (13).54
The mechanism of action of FQs is the formation of DNA-FQ-topoisomerase55
complexes and the subsequent generation of detrimental double-stranded DNA breaks56
(14). In Escherichia coli, this appears to occur through two pathways, one dependent57
and the other independent of protein synthesis. Reactive oxygen species (ROS), such as58
superoxide, hydrogen peroxide (H2O2), and hydroxyl radical, contribute to FQ-mediated59
cell death via the protein synthesis-dependent pathway (15). This observation is60
consistent with a model proposed recently suggesting that, as a consequence of gyrase61
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inhibition, hydroxyl radical are generated via the Fenton reaction (16) adding to the62
lethality of FQs (17-20). ROS production is observed with antibiotics from a variety of63
bactericidal antibiotic families in addition to FQs, each with a different intracellular64
target. However, the intervening pathways lying between the initial antibiotic-target65
interaction and ROS formation are not fully characterized, although some are beginning66
to be described (21-23). We have previously investigated these pathways for LVX in S.67
pneumoniae. We observed a global transcriptional response at concentrations of LVX68
required to inhibit the topo IV enzyme but not gyrase. This response included the up-69
regulation of fatDCEB, an operon responsible for iron uptake (Fe2+ and Fe3+). These70
were the only genes up-regulated at every concentration (0.5 MIC and 10 MIC) and71
time point studied (5, 15 and 30 min). In addition, they were the only genes varying at72
0.5 MIC and 5 min of LVX treatment. LVX-induced up-regulation of fatDCEB leads73
to an increase of intracellular iron, and in turn, to the shift in the Fenton reaction74
favoring the production of hydroxyl radical. We established a relationship between an75
increase in ROS and LVX lethality and demonstrated that local topological changes76
were involved in the up-regulation of fatDCEB. LVX did not changed global77
supercoiling. However, increases in negative supercoiling and fatDECB transcription78
after topoisomerase I inhibition were observed, while the opposite occurred after gyrase79
inhibition with novobiocin. In accordance, the fatDCEB operon is located in the80
chromosome into a topological domain down-regulated by DNA relaxation (24). We81
constructed a strain in which a Pfatcat fusion was positioned 106-kb away from the82
PfatfatDCEB native position. In this strain, up-regulation of the operon in the presence of83
LVX were observed, while no change was observed in Pfatcat. Results indicated that84
fatDCEB transcription depends on its location in a topological domain. These results85
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illustrated a link between the initial LVX interaction with its topo IV target and the86
production of ROS (25).87
We present here a complementary study whose aim was to understand the88
transcriptional response of S. pneumoniae to MOX at concentrations that inhibited89
gyrase. Chromosomal DNA fragmentation and changes in DNA topology were90
monitored. The global transcriptional response was analyzed by microarray technology.91
The results sketch a pathway from gyrase inhibition to ROS production and suggest that92
S. pneumoniae accumulates H2O2 as part of the death process associated with MOX93
treatment.94
MATERIALS AND METHODS95
Bacterial strains and conditions for growth and transformation. S. pneumoniae was96
grown in a casein hydrolysate based medium (AGCH) with 0.3% sucrose (26). The97
MICs of MOX and LVX (Sigma-Aldrich) for the R6 strain were 0.125 g/ml and 0.25098
g/ml, respectively. Two R6-derived strains, T1 and T2 (27) were also used. T1 carried99
the ParCS79F change and had MICs of 2 g/ml (LVX) and 0.125 g/ml (MOX). T2100
carried both ParCS79F and GyrAS81F changes and had MICs of 16 g/ml (LVX) and 4101
g/ml (MOX). S. pneumoniae R6 carrying the plasmid pLS1 was cultured in AGCH102
medium with 1 /g/ml tetracycline.103
Analysis of chromosomal fragmentation and of the topology of covalently closed104
circles. Chromosomal fragmentation was detected by pulse-field gel electrophoresis105
(PFGE). About 3cellswere lysed in solid agarose inserts in a buffer containing 10106
mM Tris HCl pH 8, 1 M NaCl, 0.1 M EDTA, 0.5% Brij58, 0.2% deoxycholate, 0.5%107
sarkosyl, 20 g/ml RNaseE and 100 g/ ml lysozyme. Agarose inserts were treated with108
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1 mg/ ml proteinase K and washed before to place them into a 1% low gelling agarose109
(Pronadisa) gel in 0.5%  TBE buffer (45 mM Tris-borate pH 8, 1 mM EDTA). Gels110
were electrophoresed in a Cheff-DR III System (BioRad), during 20 hours at 5.8 V/cm111
with a 0.1 to 40 seconds switch-time ramp at 14°C.Plasmid DNA isolation from S.112
pneumoniae (pLS1) was performed using the neutral method already described (28).113
Circular DNA molecules were analyzed in neutral/neutral two-dimensional agarose114
gels. The first dimension was run at 1.5 V/cm in a 0.4% agarose (Seakem; FMC115
Bioproducts) gel in 1  TBE buffer for 1719 h at room temperature. The second116
dimension was run at 7.5 V/cm in a 1% agarose gel in 1  TBE buffer for 79 h at 4ºC.117
Chloroquine (Sigma-Aldrich) was added to the TBE buffer before use. After118
electrophoresis, gels were subjected to Southern hybridization with a 240-bp probe119
specific for pLS1, as described previously (24). The DNA linking number (Lk) was120
calculated by quantifying every topoisomer. The DNA supercoiling density () was121
calculated using the equation  = Lk/ Lk0. The change in linking number (Lk) was122
determined using the equation Lk = Lk  Lk0, where Lk0 = N/10.5, N is the size of the123
molecule (in bp) and 10.5 the number of bp per one complete turn of B-DNA.124
Normalization and analysis of microarray data. High density expression arrays125
from Agilent were processed at the Functional Genomics Core Facility, Institut de126
Recerca Biomèdica, Barcelona (Spain). Arrays were designed as described (29). cDNAs127
were obtained from 25 ng of total RNA using the Trans-Plex WTA2 kit (Sigma). These128
cDNAs were labelled with Cy3 using the Agilent Genomic DNA ULS™ (Universal129
Linkage System) kit following manufacturer's instructions. A total of 250 ng of labelled130
cDNA were used for hybridization (40 hours at 65ºC) and scanning was performed with131
a Roche MS200 scanner. Raw data were extracted and normalized using Agilent132
Feature extraction software v11.5.1.1. The median expression of every probeset was133
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obtained, scaled by log2 and normalized by quantile using the Bioconductor software134
(www.bioconductor.org/). A principal component analysis was then carried out using135
the Partek Genomics Suite 6.4 and the significance of differential gene expression was136
tested using ANOVA. Each microarray experiment was carried out in duplicate with137
cDNA prepared from two independent cultures. All microarray data are available at the138
GEO (NCBI, USA) database via accession number GSE68947.139
Microarrays results were validated by quantitative real-time RT-PCR (Chromo 4,140
BioRad) as previously described (25). Genes selected to be amplified were the141
following: fatC, fatD, gyrA, gyrB, glnA, mutM, lmb, parE, psaB, pyrB spr1680, and142
topA. For most genes, previously described oligonucleotides were used (24, 25). For the143






CCCAGCATACCTTTTAATAGTGTT-3’). Annealing temperatures for the150
oligonucleotides used were comprised between 51 and 56 ºC. PCR products had sizes151
varying from 128 to 205 bp,152
Detection of ROS. The intracellular oxidation levels were measured using153
dihydrorhodamine 123 dye (Sigma-Aldrich), a non-fluorescent compound which154
diffuses across membranes. Oxidation converts it to the fluorescent product rhodamine155
123. Measured fluorescence is therefore proportional to the level of oxidation (30).156
Cells were grown to an optical density at 620 nm (OD620) = 0.4 before MOX was added.157
Samples were collected and processed as previously described (25). Fluorescence was158
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measured using a Tecan Infinite 2000 device and a filter with excitation/emission159
wavelengths of 485 nm/535 nm. Results were normalized according to the number of160
live cells at every given time point and expressed as relative fluorescence units161
(RFU)(31). Hydrogen peroxide was detected with the Amplex® Red Hydrogen162
Peroxide/Peroxidase Assay Kit (Invitrogen). Horseradish peroxidase catalyzes a163
reaction with the Amplex® Red reagent (10-acetyl-3,7-dihydroxyphenoxazine) and164
H2O2 to produce resorufin. Resorufin was detected by absorbance at 540 nm. In order to165
check the effects of MOX or LVX on the levels of H2O2, cells were grown to an optical166
density OD620 of 0.4 and then diluted 1:100 in growth media before MOX and LVX167
were added. Cells were then incubated at 37ºC for 4 hours. Samples were taken at 0, 3,168
and 4 hours, washed 3 times in PBS, resuspended in a buffer containing 100 mM169
phosphate, pH 8 and 1% deoxycholate, and incubated for 30 min at room temperature.170
The samples were centrifuged for 30 min at 10000 g and the supernatants were analyzed171
with Amplex Red. The concentration of H2O2 in samples was calculated using a172
standard curve derived from assays of serial dilutions of a defined concentration of173
H2O2. Final values were normalized according to number of viable cells.174
175
RESULTS176
MOX caused fragmentation of chromosomal DNA. MOX was tested at fully177
inhibitory (10 MIC) concentrations against the reference strain R6 carrying plasmid178
pLS1. Topoisomer distributions of the replicating pLS1 plasmid were analyzed and179
used as an estimation of changes in chromosomal supercoiling (32). At the chloroquine180
concentration used, the induced Lk is 14 (24). In the autoradiograms, topoisomers181
were found to be distributed in a bubble-shaped arc. Negative and positive supercoiled182
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molecules are located in the right or left sides, respectively. No significant differences183
in supercoiling densities () were detected under any condition. These results184
demonstrated that the inhibition of gyrase by MOX did not have a detectable effect on185
the overall level of supercoiling (Fig. 1A). However, consistent with the known186
mechanism of action of FQs (14), an increase in chromosomal fragmentation was187
observed by PFGE. The compression zone (CZ), the band in which the nicked188
fragments of chromosomal DNA that are unresolved in the gel migrate, was used to189
estimate fragmentation (33). As shown in Fig. 1B and 1C, fragmentation increased both190
with the MOX concentration used and with the time of treatment. These results are in191
agreement with the decrease in chromosomal DNA size detected by sucrose gradient192
sedimentation of E. coli cells treated with nalidixic acid (34).193
MOX triggers a global transcriptional response in S. pneumoniae. The global194
transcriptional response of R6 cells to 10 MIC (1.25 g/ml) of MOX was measured195
after 15 and 30 min. Changes in gene expression were normalized with respect to values196
at time 0. Normalized values are shown in Table 1. In total, the transcription of only 28197
genes (1.4% of the genome) varied at 15 min. The response was more pronounced at 30198
min, when the transcription of 132 genes (6.5% of the genome) varied. The responses at199
15 and 30 min were consistent: 17 out of 28 genes whose transcription had varied at 15200
min had also varied at 30 min. In addition, the transcriptional response of two R6-201
derived strains, T1 (ParCS97F; MOX MIC=0.125 g/ml) and T2 (ParCS79F,202
GyrAS81F; MOX MIC=4 g/ml) was also analysed in the presence of the same203
concentration used for R6, 1.25 g/ml, after 30 min of treatment. No significant204
responses were observed for T1 and T2 in the presence of MOX compared with not205
treatment. Only 5 genes were differentially expressed in T1, 3 being in common with206
the R6 response. For the T2 strain, only 28 genes showed differential expression, 5207
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being common to the R6 response. The transcriptome data from microarrays were208
validated by qRT-PCR. The reverse transcription products of 12 genes were measured209
with samples taken at 10 MIC of MOX. Ratios of microarray and qRT-PCR showed a210
good correlation (r2=0.75, p value= 3×104) and a slope of 0.9, indicating similar211
sensitivities for qRT-PCR and microarray hybridization (Fig. 2A).212
The transcriptional response induced by MOX in R6 was clearly different to the one213
induced by LVX. In fact, they overlapped with only 8 (29%) and 22 (17%) genes at 15214
min and 30 min, respectively (Fig. 2B). A stratified categorization of functional classes215
based on the number of responsive genes at 30 min revealed 4 gene groups (Fig. 2C).216
Group I represented >15% of the total affected genes, which included those coding for217
hypothetical proteins and membrane transport systems. These two classes were also218
predominant in the transcriptomic response to LVX (25). They form the largest group of219
genes in the R6 genome (35). No bias in the kind of regulation was observed in this220
group: about half of the genes was up-regulated while the other half was down-221
regulated. Group II represented 5-15% of the total of affected genes. These had a role in222
one of five different processes: translation, purine and pyrimidine metabolism,223
carbohydrate metabolism, transposon functions, and stress response. Biases in224
regulation were linked to the role the genes played. Genes involved in translation, which225
included translation factors and genes of ribosomal proteins, were mostly down-226
regulated (11 out of 14). However, affected genes involved in purine and pyrimidine227
metabolism were up-regulated (Fig. 3A). Most responsive genes involved in228
carbohydrate metabolism were also up-regulated, in particular, the genes of several229
pathways involved in the production of pyruvate. These included 2 genes, tktA and pmi,230
whose products convert 6P-sugars to fructose 6P. Among these were 3 out of 7231
glycolysis genes (fba, apdA, gpmA). Glycolysis is the conversion of glucose to pyruvate232
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through a fructose-6P intermediate. Meanwhile, the genes coding for acetyl-CoA233
carboxylase (accDA) were down-regulated, which would be expected to lead to an234
increase in the concentration of acetyl-CoA. This would, in turn, lead to an increase in235
the amount of pyruvate through the action of formate acetyltransferase (pfl), whose gene236
was up-regulated (Fig. 3B). Meanwhile, 8 out of the 9 genes involved in transposon237
functions were down-regulated. All responsive genes involved in stress responses were238
also up-regulated. These included the hrcA-grpE-dnaK-dnaJ and groES-groEL operons,239
which encode chaperones that modulate protein folding, promote refolding and proper240
assembly (36). Group III represented 2.5-5% of the affected genes. These included241
genes involved in pathogenesis (all 7 down-regulated); amino acid biosynthesis (4 up-242
regulated, 1 down-regulated); genes of two-component systems (3 of TCS12 up-243
regulated, 1 of TCS11 down-regulated); DNA metabolism; fatty acid metabolism; cell244
envelope; and the secG-rnr-smpB (37) operon that is involved in protein secretion245
(SecG), RNA degradation (RNaseR) and trans-translation (SmpB). Group IV246
represented <2.5% of the affected genes, and included diverse functions with no clear247
pattern in responses.248
ROS contribute to the lethality of MOX. The transcriptomic response described249
above implied an increase in the intracellular concentration of pyruvate. This would, in250
turn, lead to increases in both H2O2, through the activity of pyruvate oxidase (SpxB),251
and in hydroxyl radical, through the Fenton reaction (Fig. 3B). To assess the relevance252
of H2O2 production in MOX lethality, a previously constructed spxB-deletion mutant253
was assayed (25). This mutant produces 80% less hydrogen peroxide than the wild-type254
strain (38). Consistent with this observation, the R6spxB strain was less susceptible to255
MOX (Fig. 4A), while deletion of spxB in strains T1 and T2 did not change this256
susceptibility. No appreciable differences in susceptibility were observed in the257
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presence of the iron chelator 0-phenantroline. This result indicated that absence or258
presence of iron did not affect cell survival, despite iron being a component of the259
Fenton reaction. Meanwhile, accumulation of ROS was observed in R6 cultures treated260
with MOX (Fig. 4B). Sharp increases with respect to time 0 of 22.1-fold, 54.9-fold and261
80.8-fold were observed at 3, 4, and 5 hours of treatment, respectively. However, there262
was less than 5-fold increase for the spxB strain (Fig. 4B). Only a 15-fold increase in263
ROS was observed at 3 to 5 hours in the presence of 0-phenantroline (Fig. 4B). In264
addition, we observed a comparable increase of about 21-fold in the production of H2O2265
in R6 cultures after 3 and 4 hours with 0.5× MIC of MOX (Fig. 4C). However, no266
increase was detected in the presence of LVX. A plausible interpretation is that the 15-267
fold increase of signal in the presence of 0-phenantroline, happens independently of the268
Fenton reaction and is really a consequence of an increase in H2O2, which was also269
detected by dihydrorhodamine 123. These results suggest a link between MOX lethality270
and the Fenton reaction via an increase of H2O2. In summary, ROS contributes to the271
lethality of MOX in two ways: directly by an increase in endogenous H2O2 and272
indirectly via the Fenton reaction. No increases in the production of H2O2 in the T1 and273
T2 strains with respect to the time 0 min were observed in the presence of MOX. This is274




In an effort to understand the transcriptional alterations mediated by inhibitors of DNA279
topoisomerases we analyzed the global transcriptomic response of S. pneumoniae to280
MOX. As far as we are aware, this is the first study of the effects of this drug on281
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transcription in pathogenic bacteria. In order to selectively inhibit gyrase, we used 10×282
MIC of MOX. At this concentration gyrase was expected to be fully inhibited.283
However, the possibility could not be discarded that topo IV was also partially inhibited284
(13, 39, 40). To test this possibility, the transcriptomic responses of two isogenic285
strains, T1 (as R6, ParCS79F) and T2 (as R6, ParCS79F, GyrAS81F), were analyzed.286
No significant transcriptional response was detected in any strain, suggesting that topo287
IV is also inhibited by MOX at this concentration. In accordance, treatment of T1 with288
MOX caused the inhibition of growth, although the decrease in viability detected in R6289
was not observed (Fig. 4A). Likewise, no inhibition of growth was detected in T2.290
A global transcriptional response induced by MOX in R6 was observed. A291
similar number of genes were affected with MOX as with LVX at 10× MIC, however,292
these had different patterns (25). Those genes whose transcription varied in the control293
(non-treated) culture were considered growth-related genes and were filtered out in the294
analysis of the treated cultures (25). When excluding these genes, we found that were295
only 2 genes similarly affected by LVX and MOX at 15 min. At 30 min treatment, 15296
genes were similarly affected. From these results we can conclude that the297
transcriptomic responses to treatment with LVX or MOX are different, given that a low298
proportion of the responsive genes were similarly affected. These differences revealed299
the different modes of action of the two drugs: LVX inhibited topo IV (12, 13, 40), and300
MOX inhibited both topo IV and gyrase.301
However, LVX and MOX affected the activation of competence in a similar302
fashion. We previously observed that, over time, a control culture had a general down-303
regulation of the 53 genes of the competence regulon (25). Meanwhile, treatment with304
LVX led to a decrease in this down-regulation (25). The effect was even stronger with305
MOX: down-regulation was reversed and even up-regulation was observed in the case306
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of three competence genes (Table 1), including the gene coding for the alternative sigma307
factor ComX, which activates transcription of late competence genes (41, 42). Thus308
activation of competence in S. pneumoniae is a common stress response to FQs in a309
bacterium that lacks an SOS-like system (43).310
We have not detected changes in general supercoiling neither with LVX (25) or311
MOX treatments. However, we observed a different pattern of gene expression312
alteration with these drugs. A possibility is that the transcriptional alterations induced313
by MOX and LVX are due to local changes in supercoiling, which are dependent on314
whether topo IV (LVX) or gyrase (MOX) are inhibited. We have proved that this is the315
case for the fatCDE operon (25). Since both topo IV and gyrase produce double-316
stranded breaks in the DNA when inhibited by FQs, the differential transcriptional317
alterations caused by these drugs could also be related to differences in sequence318
recognition (44), which is affected by DNA supercoiling and bendability (45). Sequence319
recognition mediated by local supercoiling levels might explain the unique distribution320
of the genes affected by LVX or MOX (Fig. 2C). In addition, the location of the FQ-321
topoisomerase complexes relative to the replication forks, which is different for gyrase322
and topo IV (46), could also have a role in the different transcription alterations.323
Several genes related to purine and pyrimidine metabolism were up-regulated324
with MOX but not with LVX. Among them was prsA, coding for an enzyme that325
catalyzes the synthesis of 5-phospho ribosyl--1-pyrophosphate (PRP). PRP is an326
intermediary in both purine and pyrimidine metabolism (47). The product of pyrP is a327
dedicated transporter that facilitates the entrance of uracil into the cell. Uracil is328
converted to UMP by the product of upp. The intracellular concentration of UMP would329
be expected to increase through the activation of the CO2 biosynthesis pathway: 6 out of330
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the 8 these genes were up-regulated (Table 1, Fig. 3A). These genes are regulated by an331
attenuator mechanism and would form part of the PyrR regulon. PyrR senses UMP332
levels and when the concentration is high, it binds to both UMP, and the antiterminator,333
impeding the transcription of downstream genes. As in other lactic acid bacteria (47),334
the pyrFE, pyrK, and pyrR-pyrB-carA-carB genes would be modulated by this system.335
The pathways affecting pyruvate levels were up-regulated by MOX but not by336
LVX. These pathways include the tktA and pmi genes, which encode enzymes that337
convert ribulose-5P to fructose-6P and manose-6P to fructose 6P, respectively. They338
also include 3 out of 7 genes of the glycolysis pathway (Fig. 3B). Likewise, acetyl-CoA339
carboxylase was down-regulated in a MOX-dependent manner, likely leading to an340
increase in acetyl-CoA levels. This increase would lead to increased production of341
pyruvate by formate acetyltransferase (pfl), also up-regulated by MOX. An increase in342
pyruvate would lead to a parallel increase, mediated by SpxB, in intracellular H2O2.343
This would, in turn, increase the amount of hydroxyl radical produced though the344
Fenton reaction. We observed comparable increases in the production of H2O2 and345
hydroxyl radical as a result of MOX treatment (Fig. 4).346
We have demonstrated that ROS have a role in the lethality of MOX in S.347
pneumoniae R6. Consistent with this model, the R6spxB and T1 strains were less348
susceptible to this drug (Fig. 4). These results support a model whereby the accelerated349
production of redox alterations by FQs contributes to their lethality (18, 20). Also350
consistent is the fact that glutathione reductase (gor) gene was up-regulated, presumably351
in an attempt to counteract the lethal level of oxidation. Glutathione reductase reduces352
glutathionine (-L-glutamyl-L-cysteinyl-glycine) which lowers the level of oxidation.353
This provides protection from H2O2 accumulation (48).354
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Stress-related genes coding for chaperones were also up-regulated by MOX.355
These were the hrcA-grpE-dnaK-dnaJ and groES-groEL operons. These operons are356
induced in bacteria by a wide variety of stresses, including starvation, exposure to free357
radicals, and heat shock. In S. pneumoniae the hrcA-grpE-dnaK-dnaJ operon is also358
known to be regulated by heat shock (49). In addition, the secG-rnr-smpB (37) operon359
was down-regulated in the presence of MOX. This operon codes for the SecG integral360
membrane protein that forms part of the SecYEG complex, which is involved in protein361
secretion. The operon also codes for RNaseR, involved in RNA degradation, and SmpB,362
which mediates trans-translation. This operon is also regulated by stress and is up-363
regulated by cold-shock (37). In addition, lepA, the gene coding EF-4, which is involved364
in trans-translation, is also down-regulated (Table 1). In E.coli, LepA contributed to365
ROS lethality (50). Then, down-regulation would be a protective effect. In this light, a366
reduction in the repair systems increases MOX lethality in Mycobacterium smegmatis367
(51). Whether or not these operons are regulated by ROS in S. pneumoniae remains to368
be determined.369
The results presented here complement our previous findings that LVX, an370
inhibitor of topo IV, triggers the transcriptional activation of iron transport genes (25), a371
result not observed with MOX. Both LVX and MOX stimulate the Fenton reaction by372
causing an increase in the concentration of either iron or H2O2, respectively. In addition373
to causing hydroxyl radical to accumulate, MOX increases endogenous H2O2, which has374
been shown to alter membrane composition (52) and survival (53) in S. pneumoniae.375
This study suggests that a strategy for improving the efficacy of FQs may be to376
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FIG 1. Global supercoiling did not vary under treatment of S. pneumoniae R6 (pLS1)561
with MOX, although chromosomal DNA became fragmented. Cultures in AGCH that562
reached the exponential phase at OD620 = 0.4 were treated with MOX at 10× MIC.563
Samples were taken before the addition of the drug (0 time), and, at the indicated times,564
plasmid DNA was isolated and subjected to two-dimensional agarose gel565
electrophoresis. (A) First dimension run in the presence of 1 g/ml chloroquine and566
second dimension run in the presence of 2 g/ml chloroquine. Indicated supercoiling567
density () values are average ± SD of three independent replicates. An open arrowhead568
indicates the topoisomer that migrated with Lk = 0 in the second dimension and that569
has a Wr = 14. A blackened arrowhead points to the more abundant topoisomer. (B)570
PFGE gel of R6 at the indicated times and MOX concentrations. CZ, compression zone.571
(C) Quantification of the fragmentation: signal in the CZ divided by the combined572
signal of the lane plus well. Results are represented as the mean  SD of three573
independent replicates.574
FIG 2. Gene expression analysis in the two conditions assayed. (A) Correlation of the575
changes in RNA transcript levels using data from qRT–PCR and microarray576
hybridizations . (B) Localization of responsive genes in the chromosome of S.577
pneumoniae. The relative fold variation of each gene is plotted against the location of578
the 3’ end of each open reading frame in the S. pneumoniae R6 chromosome (bases 1 to579
2038615). (C) Classification of responsive genes by functional classes: AaB, amino acid580
biosynthesis; CaM, carbohydrate metabolism; CE, cell envelope; DNA, DNA581
metabolism; Pat, pathogenesis; Str, stress; FaM, fatty acid metabolism; PPy, purines and582
pyrimidines metabolism; TCS, two-component systems; Tr, translation; TBP, transport583
26
and binding proteins; Hy, hypothetical proteins; Tns, transposon functions; Oth, other584
(classes with a representation < 2.5%). Column colors: black , up-regulated responsive585
genes, white, down-regulated responsive genes.586
FIG 3. The regulation of two metabolic pathways by MOX treatment would yield587
increases in UMP (A) or pyruvate (B). The increase in pyruvate would produce a588
consequent increase in hydrogen peroxide, and in turn, to an increase in hydroxyl589
radical by the Fenton reaction.590
FIG 4. MOX lethality is linked to the level of intracellular hydrogen peroxide. (A)591
Viability of S. pneumoniae strains either in AGCH, or in AGCH plus MOX at 0.125592
g/ml (1× MIC for R6 and T1). Values normalized to the 0 time value. The mean 593
SEM of three independent replicates is shown. (B) Accumulation of reactive oxygen594
species, measured using dihydrorhodamine 123 dye, a non-fluorescent compound which595
in converted by oxidation to fluorescent rhodamine 123. Strains R6 and R6spxB were596
grown to an optical density at 620 nm (OD620) = 0.4 before MOX at 1× MIC was added,597
samples were processed and fluorescence was measured as described in methods. RFU,598
relative fluorescence units; values were divided by the number of viable cells. (C)599
Accumulation of hydrogen peroxide in the indicated conditions, detected with the600
Amplex® Red Hydrogen Peroxide/Peroxidase Assay Kit as described in methods. Cells601
were grown to OD620=0.4 and then diluted 1:100 in growth media before MOX and602
LVX were added, both at 0.06 g/ml (0.5× MIC for R6). Cells were then incubated at603
37ºC for 4 hours. Samples were taken at 0, 3, and 4 hours, processed as described in604
methods. Values are calculated as concentration of hydrogen peroxide in µM605
normalized against the number of viable cells and calculated as the fold-difference with606
respect the initial 0 time value.607
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608
TABLE- 1. Genes involved in the transcriptomic response of S. pneumoniae to 30 min609
treatment with MOXa610





Amino acid biosynthesis: Asp spr1907 (dapD) 2.0
Amino acid biosynthesis: Gln spr0443*-0444 (glnRA) 2.0
Amino acid biosynthesis: Ser spr1095 (metY) 3.9
spr0823 (but) -2.3
Biosynthesis of cofactors spr1324 (apbE) -2.8








pathway spr1841 (tktA) 2.8





Cell envelope spr1459 (gtrB) 2.9
spr0540*-0541 (murMN) 2.1
Cellular processes: Detoxification spr0864 (lguL) -2.3









Cellular processes: Cell division spr0844 (gidA) 2.2
Cellular processes: Toxin production spr0880 (tehB) -2.1
Central intermediary metabolism spr0816 (cad) -2.4
spr0284 (xylS) 2.1
DNA metabolism spr0673 (holA) 2.3
spr0790 (hsdR) 2.6
spr0872 (mutM) -2.0
Fatty acid metabolism spr0386*-0387 (accDA) -2.2
Protein Export and Trans-translation spr0877*-0879 (secG-rnr-smpB) -2.7















Translation spr0682 (rpsP) -2.1










Transport: Amino acids, peptides and






Transport: Anions spr0648 3.1
Transport: Sugars spr0063 -2.1
spr1566
spr1836 









a The responsive genes included in this list showed significant fold variations (2 and P612
0.01). All genes showing variations are included, with the exception of 22 encoding613
32
hypothetical proteins and 7 encoding transposases. Genes involved in the growth-related614
response are not included. Genes affected in both the response to LVX and to MOX615
response are shown in boldface. Symbols: * the first gene of the operon; °gene with a616
ComE box; , no change.617
b In operons, values indicated correspond to those of the first gene of the operon. Values618
above 2 are shown in boldface.619
620
621
622
